Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript
Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31204 EPS, expectations were $-0.21.
Co-Diagnostics Inc. (CODX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 72,931 | $81,683 | -25% | 0% |
| 2. | D E Shaw D. E. Shaw | 46,305 | $51,862 | 0% | |
| 3. | 22,900 | $25,648 | -69% | 0% | |
| 4. | Engineers Gate Manager Greg Eisner | 12,119 | $13,573 | 0% | |
| 5. | GLG Partners Noam Gottesman | 10,637 | $11,913 | -86% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.90 | 3,000 | Officer | 76,236 | 2023-03-20 | Filing | |
| $1.82 | 1,305 | Large Shareholder, Officer, Director | 2,275,000 | 2018-05-11 | Filing | |
| $1.91 | 500 | Large Shareholder, Officer, Director | 2,273,695 | 2018-05-03 | Filing | |
| $2.02 | 500 | Large Shareholder, Officer, Director | 2,273,198 | 2018-04-23 | Filing | |
| $1.94 | 500 | Large Shareholder, Officer, Director | 2,272,698 | 2018-04-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.46 | 2,000 | 0 | 2021-09-08 | Filing | ||
| $8.53 | 1 | 0 | 2021-05-19 | Filing | ||
| $8.52 | 97,413 | 1 | 2021-05-19 | Filing | ||
| $8.54 | 10,920 | 97,414 | 2021-05-19 | Filing | ||
| $11.00 | 38,046 | Officer, Director | 0 | 2021-01-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,781,283 | $2,369,107 | 0% | |
| 2. | 501,830 | $667,434 | 0% | |
| 3. | 294,422 | $391,678 | 0% | |
| 4. | 272,900 | $362,957 | 0% | |
| 5. | 145,621 | $193,676 | 0% |
News See All
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Co-Diagnostics Fourth Quarter and Full Year 2023 Earnings Conference Call. All participants will be in listen-only mode.
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2023 Earnings Call Transcript
Operator: Hello. Welcome to the Co-Diagnostics Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Co-Diagnostics Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Co-Diagnostics’ First Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded today.
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Co-Diagnostics, Inc. Fourth Quarter and Full Year 2022 Earnings Results Conference Call. All participants will be in a listen-only mode.
Co-Diagnostics, Inc. (CODX) Fell Out Of Favor With Hedge Funds
In this article we will analyze whether Co-Diagnostics, Inc. (NASDAQ:CODX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Where Do Hedge Funds Stand On Co-Diagnostics, Inc. (CODX)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
At its worst on March 23rd, Dow Jones and the S&P declined by around 37% and 34%. At the time, those kinds of numbers represented a loss of a 3-year gain since Trump’s election in November of 2016.
Financial Advisors Find Silver Lining In Gilead Sciences, Moderna Amid Coronavirus Worries
Last week, US stocks dropped firmly and settled in the connection territory as threat from the coronavirus pandemic wreaked havoc among investors.
Billionaire Hedge Funds
